Submission Of Bioequvalence (BE) Study Reports For Registered Generic Products In The Form Of Effervescent, Dispersible, Orodispersible, Sublingual, Buccal And Chewable Tablets/Capsules For The Purpose Of Re-Registration (Renewal)

User Rating: 3 / 5

Star ActiveStar ActiveStar ActiveStar InactiveStar Inactive
 

 Kindly take note that BE study reports for re-registration purposes should ONLY be submitted to NPRA within six (6) to twelve (12) months prior to the expiry of the validity period of the product registration. This is to align the work processes, as well as to ensure that the BE study report evaluation reviews are in line with the re-registration process of generic products.

 

[Directive –Bil (27) dlm BPFK/PPP/07/25]
[Directive –Bil (45) dlm BPFK/PPP/01/03]

National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

  • Phone: +603-7883 5400

 

 

Image   Image   Image   Image  

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Site Last Modified

  • Last Modified: Tuesday 23 April 2024, 09:29:46.
© Copyright 2023 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Search

Main Menu English

Industry Menu